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Deficits are Unrelated in Parkinson’s 
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Giovanni Fabbrini1,2 and Alfredo Berardelli1,2*
1 Department of Neurology and Psychiatry, Sapienza University of Rome, Rome, Italy, 2 Neuromed Institute IRCCS, Pozzilli, 
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Background: Altered emotional processing, including reduced emotion facial expres-
sion and defective emotion recognition, has been reported in patients with Parkinson’s 
disease (PD). However, few studies have objectively investigated facial expression 
abnormalities in PD using neurophysiological techniques. It is not known whether altered 
facial expression and recognition in PD are related.
Objective: To investigate possible deficits in facial emotion expression and emotion 
recognition and their relationship, if any, in patients with PD.
Methods: Eighteen patients with PD and 16 healthy controls were enrolled in this study. 
Facial expressions of emotion were recorded using a 3D optoelectronic system and ana-
lyzed using the facial action coding system. Possible deficits in emotion recognition were 
assessed using the Ekman test. Participants were assessed in one experimental session. 
Possible relationship between the kinematic variables of facial emotion expression, the 
Ekman test scores, and clinical and demographic data in patients were evaluated using 
the Spearman’s test and multiple regression analysis.
results: The facial expression of all six basic emotions had slower velocity and lower 
amplitude in patients in comparison to healthy controls (all Ps <  0.05). Patients also 
yielded worse Ekman global score and disgust, sadness, and fear sub-scores than 
healthy controls (all Ps < 0.001). Altered facial expression kinematics and emotion rec-
ognition deficits were unrelated in patients (all Ps > 0.05). Finally, no relationship emerged 
between kinematic variables of facial emotion expression, the Ekman test scores, and 
clinical and demographic data in patients (all Ps > 0.05).
conclusion: The results in this study provide further evidence of altered emotional 
processing in PD. The lack of any correlation between altered facial emotion expression 
kinematics and emotion recognition deficits in patients suggests that these abnormalities 
are mediated by separate pathophysiological mechanisms.
Keywords: Parkinson’s disease, bradykinesia, hypomimia, emotion, motor control
Abbreviations: AUs, action units; FACS, facial action coding system; H&Y, Hoehn & Yahr scale; MDS-UPDRS, movement 
disorder society-sponsored revision of the unified Parkinson’s disease rating scale; PD, Parkinson’s disease.
TaBle 1 | Demographic and clinical characteristics of participant groups.
PD patients hs P-values
Gender ratio 7F/11M 6F/10M 0.93
Age 58.8 ± 5.5 61.2 ± 9.8 0.54
Education 11.8 ± 4.2 10.8 ± 4.3 0.65
Disease duration 5.9 ± 2.3 – –
Movement disorder society-
sponsored revision of the 
unified Parkinson’s disease 
rating scale (part III)
16.9 ± 3.9 – –
LEDD 394.44 ± 181.31 – –
PD, Parkinson’s disease; HS, healthy subjects; F, females; M, males; LEDD, levodopa 
equivalent daily dose.
Age, education, and disease duration are expressed in years. Data given are 
means ± 1 SD.
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inTrODUcTiOn
Parkinson’s disease (PD) is a neurodegenerative disease charac-
terized by motor and non-motor symptoms (1, 2). Although the 
main pathophysiological mechanism of PD is the dopaminergic 
denervation of the basal ganglia (3, 4), other structures are 
involved. Indeed, the cingulate cortex and amygdala are also 
known to be involved in the neurodegenerative process of PD 
(5–8). Therefore, a proportion of patients suffer from altered 
emotional processing (9, 10).
Accordingly, spontaneous facial expressivity has consistently 
been reported to be impaired in PD (11–16). The ability to 
mimic a facial expression shown in a picture (posed emotions) 
has been reported to be either normal (16) or impaired (15, 17, 
18). However, there is a limited amount of information avail-
able regarding the objective assessment of facial expressions of 
the basic emotions in PD using neurophysiological techniques 
(16, 19–21). By contrast, facial emotion recognition has been 
extensively investigated in PD patients (22). Impaired emotion 
recognition has consistently been reported for disgust (23–26), 
whereas data on other emotions are less concordant (27–33). 
One important issue that has yet to be clarified is whether a rela-
tionship exists between facial emotion expression abnormalities 
and facial emotion recognition deficits in PD and whether 
these two deficits share the same underlying pathophysiologi-
cal mechanisms (19, 21, 34). This information would provide 
a deeper insight into the pathophysiology of altered emotional 
processing in PD patients.
The aim of this study was to investigate whether possible 
deficits of facial emotion expression in PD patients are related 
to other aspects of emotional processing, such as emotion rec-
ognition. For this purpose, we first kinematically assessed the 
facial expression of the six basic emotions, i.e., anger, disgust, 
fear, happiness, sadness, and surprise, in PD patients, and 
then assessed possible deficits in facial emotion recognition by 
means of the Ekman test in the same sample of patients. Finally, 
we investigated the possible relationship between kinematic 
abnormalities of facial emotion expression, emotion recognition 
deficits, and clinical or demographic data. Data from PD patients 
were compared with those obtained from a sample of healthy 
control subjects.
MaTerials anD MeThODs
Participants
Patients were recruited from the outpatient clinic of the 
Department of Neurology and Psychiatry, Sapienza University 
of Rome. Eighteen PD patients were completed the study [seven 
women, mean age ± 1 SD: 58.8 ± 5.5]. Sixteen healthy subjects 
(HS) (six women, mean age ± 1SD: 61.2 ± 9.8)—matched for age, 
gender, and educational level—were included as a control group 
(Table 1). The diagnosis of idiopathic PD was based on clinical 
criteria (1, 2, 35). Motor symptoms and disease staging were 
assessed by means of the movement disorder society-sponsored 
revision of the Unified Parkinson’s Disease Rating Scale (MDS-
UPDRS part III) scale (36–38) and Hoehn & Yahr staging scale 
(H&Y). Patients were excluded if they had dementia or other 
neuropsychiatric disturbances (such as depression, anxiety, or 
psychosis) as defined by means of the DSM-IV criteria; other 
exclusion criteria were involuntary facial movements and a 
history of facial trauma or paralysis that might interfere with 
facial movements. All the participants were right handed, and 
none of them were taking drugs that act at the central nervous 
system level other than antiparkinsonian medications for the PD 
patients. All the patients were stable responders to dopaminergic 
medication (i.e., levodopa and extended-release dopamine ago-
nists, alone or in combination) and tested at the same time of 
the day while they were on their usual therapeutic regimen. In 
PD patients, the total l-DOPA equivalent daily dose (LEDD) was 
calculated as in Tomlinson et al. (39). We assessed patients in the 
ON medication state because we did not detect any significant 
effect of dopaminergic medications on facial movements, includ-
ing voluntary blinking and posed smiling kinematics, in previous 
studies (18, 40, 41). All the subjects gave their written informed 
consent. The study was approved by the local institutional review 
board, and experiments conformed to the regulations laid down 
in the Declaration of Helsinki.
Kinematic recordings and analysis 
of Facial expression
Facial movements were recorded using a 3D optoelectronic 
system (SMART motion system, BTS Engineering, Milan, Italy). 
This system comprises three infrared cameras (sampling rate, 
120  Hz) that follow the 3D displacement of reflective markers 
taped on the face of the subjects. We used 21 reflective markers 
of negligible weight. Four markers were placed on the medial and 
lateral part of the eyebrow (bilaterally). Two markers were placed 
on the middle of the lower eyelids. Two markers were placed 
over the nasolabial furrows. Two markers were positioned on 
the labial corners. Four markers were placed on the medial and 
lateral part of the superior and inferior lips. Finally, one marker 
was placed over the chin. Head movement contaminations were 
avoided by using three additional markers placed over the tip 
of the nose and over the zygomatic process of the temporal 
bone, bilaterally. A software (SMART Analyzer, BTS Engineering, 
Milan, Italy) reconstructed the 3D spatial displacement of the 
reflective markers off-line and determined the kinematic features 
of the facial expressions (i.e., the peak velocity and amplitude).
TaBle 2 | Kinematic variables of facial emotion expressions in patients with Parkinson’s disease (PD) and in healthy subjects (hs).
Peak velocity amplitude
PD patients hs P values PD patients hs P values
anger
Brown lowerer—AU4 23.57 ± 4.51 32.89 ± 4.77 0.097 3.25 ± 0.60 4.69 ± 0.81 0.147
Upper lip raiser—AU10 22.21 ± 3.45 39.74 ± 4.90 0.015* 2.17 ± 0.28 5.76 ± 1.31 0.015*
Jaw drop—AU26 50.07 ± 11.38 131.29 ± 63.41 0.128 7.18 ± 1.41 12.17 ± 2.46 0.078
Disgust
Nose wrinkler—AU9 22.02 ± 4.85 42.50 ± 6.54 0.015* 3.58 ± 0.56 6.68 ± 0.79 0.004*
Lip corner depressor—AU15 23.78 ± 3.83 33.23 ± 9.54 0.427 4.81 ± 0.99 6.87 ± 1.13 0.062
Jaw Drop—AU26 33.83 ± 6.77 52.14 ± 13.46 0.580 7.33 ± 1.51 10.77 ± 2.34 0.254
Fear
Inner brown raiser—AU1 18.15 ± 2.44 35.67 ± 3.57 0.010* 2.30 ± 0.38 3.52 ± 0.35 0.128
Outer brown raiser—AU2 27.58 ± 2.78 47.91 ± 7.00 0.006* 2.80 ± 0.42 4.50 ± 0.45 0.027
Jaw drop—AU26 45.28 ± 9.54 123.42 ± 28.60 0.045 8.75 ± 2.32 14.12 ± 3.68 0.097
happiness
Cheek raiser—AU6 17.74 ± 4.17 40.44 ± 6.60 0.004* 2.53 ± 0.37 6.03 ± 0.95 <0.001*
Lip corner puller—AU12 30.26 ± 4.76 53.03 ± 7.17 0.005* 5.01 ± 0.57 8.98 ± 1.16 0.005*
sadness
Brown lowerer—AU4 7.82 ± 1.09 13.91 ± 2.17 0.009* 1.31 ± 0.24 1.97 ± 0.34 0.097
Lip corner depressor—AU15 9.86 ± 1.61 18.57 ± 2.49 0.001* 1.70 ± 0.27 3.36 ± 0.43 0.001*
surprise
Inner brown raiser—AU1 25.90 ± 3.35 46.14 ± 4.99 0.002* 2.88 ± 0.40 4.04 ± 0.52 0.012
Outer brown raiser—AU2 32.26 ± 3.60 54.26 ± 4.44 0.001* 3.66 ± 0.39 4.86 ± 0.41 0.053
Jaw drop—AU26 60.59 ± 9.07 156.20 ± 41.02 0.008* 10.09 ± 1.95 17.20 ± 4.89 0.090
Plus and minus values are mean ± 1 SEM. Data of all the action units (AU), except AU26, are pooled from both hemifaces.
*Statistically significant between group difference.
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We quantified the facial expressions of emotions using the 
facial action coding system, which distinguishes 44 different 
action units (AUs) produced by a single muscle or a combination 
of muscles (42, 43). For this analysis, we selected and assessed 
the kinematics of the main and most consistent AUs that reflect 
each specific emotion (Table  2). In order to generate a single 
measurement, we also computed composite scores by calculating 
the average values of the AUs selected for each facial expression 
of emotion.
Facial expressions were studied by asking participants to 
voluntarily mimic the six basic emotions, i.e., anger, disgust, fear, 
happiness, sadness, and surprise, so as to achieve the highest 
expressiveness possible for each emotion. The examiners moni-
tored the correct execution of the task online. Incongruent facial 
expressions were rejected online.
assessment of emotion recognition
Emotion recognition deficits were evaluated in all the participants 
by means of the Ekman 60 Faces test. Pictures of 10 actors’ faces 
(5 males and 5 females) expressing each of the six basic emotions, 
i.e., anger, disgust, fear, happiness, sadness, and surprise, were 
presented on a computer screen one at a time. Participants were 
asked to identify the emotions represented in the pictures in a six 
forced-choice response format. Response time was unlimited, but 
participants were encouraged to respond as quickly as possible. 
The test yields a score out of a maximum of 60 for the recognition 
of all six emotions or scores out of 10 for the recognition of each 
basic emotion.
statistical analysis
Gender differences between PD patients and HS were assessed 
by means of the Chi-square (χ2) test. Possible differences in age 
and years of education, in the kinematic variables of the main 
AUs reflecting each specific basic emotion, and in the Ekman test 
scores (including the global score and the sub-scores of the six 
basic emotions) between PD patients and HS were evaluated by 
means of the Mann–Whitney U-test. Data from the hemiface cor-
responding to the more affected side of the body and the hemiface 
corresponding to the less affected side of the body in patients, 
and right and left hemiface in HS, were pooled together as no 
significant difference emerged between the two sides of the faces 
in a preliminary analysis using the Wilcoxon matched-pairs test 
(see Results). The peak velocity and amplitude of the AUs reflect-
ing each emotion were assessed in a separate analysis (Table 2).
Possible relationship between the kinematic variables of 
facial emotion expression and the Ekman test scores were 
assessed by the Spearman rank order correlation analysis. 
Subsequently, we also performed a multiple regression analysis 
using the demographic and clinical data of PD patients, i.e., age, 
years of education and disease duration, the MDS-UPDRS (part 
III) global score, hypomimia or bradykinesia items and LEDD, 
as independent variables and kinematic variables of facial 
emotion expression, and the Ekman test scores as dependent 
variables.
Unless otherwise stated, results are indicated as mean val-
ues ±  1 SEM. Bonferroni’s correction was applied to multiple 
comparisons and correlations.
FigUre 1 | results of the ekman 60 Faces test in healthy subjects—
gray histograms and in patients with Parkinson’s disease—black 
histograms. The X axis indicates the global score and sub-scores for the six 
basic emotions during the Ekman test; the Y axis indicates the percentage of 
correct responses in each group. Vertical bars indicate 1 SD. Asterisks 
indicate statistically significant between group difference.
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resUlTs
Demographic and clinical assessments
No significant differences in gender distribution, age, or years 
of education were observed between PD patients and HS (all 
Ps > 0.05, Table 1).
Facial emotion expressions
A preliminary analysis showed no peak velocity and amplitude 
difference between the hemiface corresponding to the most 
affected side of the body and the hemiface corresponding to the 
less affected side of the body in PD patients, and right and left 
hemiface in HS, for all the AUs examined (all Ps > 0.05). Data of 
the two sides of the faces were then pooled together for a subse-
quent between-group analysis showing no significant difference 
for the peak velocity and amplitude in various AUs examined 
between PD patients and HS (Table 2). The analysis revealed that 
the kinematic variables were overall lower in PD patients than in 
healthy controls for all the six basic emotions analyzed (Table 2). 
To sum up, when compared with HS, PD patients displayed an 
overall and aspecific reduction in facial motor activation during 
facial emotion expression (Table 2).
Facial emotion recognition
The overall Ekman score of the PD group was significantly lower 
than that of the HS (P < 0.001). The analysis yielded significantly 
lower scores for the sub-scores of disgust, fear, and sadness in PD 
patients than in HS (all P < 0.001) and a difference approaching 
significance between the two groups for the sub-score of anger 
(P  =  0.01, corrected alpha level 0.008). No differences were 
detected between the two groups in the recognition of happi-
ness and surprise (both P ≥ 0.05). To sum up, when compared 
with HS, PD patients displayed an overall reduction in emotion 
recognition, due to a specific deficit in the recognition of disgust, 
sadness, and fear (Figure 1).
relationship between Kinematic Data, 
ekman Test scores, and Demographic and 
clinical Data
The Spearman rank order correlation analysis showed no rela-
tionship between the composite scores of both peak velocity and 
amplitude for the six basic emotions, i.e., anger, disgust, fear, 
happiness, sadness, and surprise, and the emotion recognition 
deficits in PD patients (all Ps > 0.05). Multiple regression analysis 
detected no relationship between demographic and clinical data, 
i.e., age, years of education and disease duration (in years), as 
well as motor symptom severity, i.e., the MDS-UPDRS (part III) 
global score, hypomimia or bradykinesia items, and LEDD, and 
kinematic data or Ekman test scores (all Ps > 0.05).
DiscUssiOn
The results of this study indicate that facial expression of anger, 
disgust, fear, happiness, sadness, and surprise and recognition of 
disgust, sadness, and fear are impaired in PD patients. We did 
not detect any correlation between facial expression kinematic 
abnormalities and emotion recognition deficits in patients, which 
suggests that different pathophysiological mechanisms underlie 
these two abnormalities.
There may be several reasons for deficits in facial emotion 
expression and recognition in PD patients, such as dementia, 
neuropsychiatric disorders, and other diseases of the facial region, 
including dyskinesia and facial palsy. However, we ruled out the 
possibility that they might have affected the results in our patients 
by including these conditions among the exclusion criteria. Since 
we also excluded patients treated with psychotropic medications 
(other than dopaminergic medications), we also rule out the 
possibility that impaired emotion expression and recognition are 
due to aspecific numbing or blunting, which are common side 
effects of several drugs that act at the level of the central nervous 
system. Finally, since the demographic and clinical data of the PD 
patients and HS were similar, we also rule out any confounding 
effect of these features.
The results of the kinematic evaluation of the facial expres-
sions of anger, disgust, fear, happiness, sadness, and surprise in 
PD patients compared with HS point to an overall, aspecific slow-
ness, i.e., bradykinesia, of facial emotion expression as assessed by 
the kinematic analysis of specific AUs of each basic emotion. The 
results also extend the observations reported in previous studies 
on PD patients by revealing kinematic abnormalities in spontane-
ous and posed smiling (13, 14, 18), as well as those of more recent 
studies on facial mimicry deficits, as assessed by EMG (19, 21). 
Voluntary facial movements, including expressions of emotions, 
are primarily mediated by primary and non-primary motor 
cortical areas in the frontal lobe through direct corticobulbar 
projections to the facial motor nucleus (11, 44). In particular, 
the motor areas in the medial wall of the frontal lobe, including 
the supplementary motor area and cingulate cortex, are involved 
in generating voluntary movements associated with emotional 
expression (45). Our findings support the hypothesis that in PD 
a basal ganglia dysfunction might interfere with both primary 
and non-primary motor area activation in the frontal lobe, 
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thereby resulting in an aspecific slowness of the facial expression 
of emotion.
In this study, we found that movement slowness during all the 
facial expressions of emotions affected both the upper and lower 
hemifaces. These results, which are in keeping with previous 
findings, indicate that muscle hypoactivation and slower move-
ments of the lower face in patients with PD than in HS during the 
expression of facial emotions (18, 19, 21). By contrast, the results 
of previous studies have shown that the ability of PD patients to 
voluntarily perform stereotyped movements, such as blinking, 
is relatively well preserved, there being no evidence of altered 
velocities or amplitudes (40, 41, 46). Since the muscles of the 
peri-orbital region (upper face), particularly those of the eyelid, 
are characterized by low inertia and are innervated bilaterally, 
they are less likely to be impaired than the muscles in the mouth 
area (lower face), which are cross-innervated prevalently from 
the contralateral side (11, 44, 45). Another explanation is that 
complex facial movements that require the integration of afferent 
influences from limbic structures (9, 11), such as emotion expres-
sions, are more susceptible to impairment than more stereotyped 
movements, such as blinking.
Clinical observations indicate that more severe facial expres-
sion deficits, i.e., hemihypomimia, may be observed to the most 
affected side of the body and to the side of the body on which 
symptoms start in a low proportion of patients with PD (47, 48). 
We did not observe any differences in the kinematic features 
of the six basic emotions between the left and right hemifaces 
in healthy controls, or between the hemiface ipsilateral or 
contralateral to the most severely affected side of the body in 
PD patients. The present findings extend previous clinical 
observations and kinematic findings based on the evaluation 
of posed smiling (18) and suggest that there is no significant 
hemiface difference in facial motor activation in the majority 
of PD patients.
An innovative feature of this study is the evaluation we 
performed to investigate whether any relationship exists 
between deficits in facial emotion expression (by means of 
the kinematic analysis) and emotion recognition to determine 
whether these abnormalities are related to altered connectivity 
between the emotion-related activation of limbic structures and 
downstream motor effectors. In our PD sample, we detected 
kinematic abnormalities in all six basic emotions, whereas emo-
tion recognition deficits were observed specifically for disgust, 
fear, and sadness. Moreover, we did not detect any correlation 
between individual deficits in emotion expression and recogni-
tion. Our results thus indicate that these two abnormalities that 
reflect altered emotional processing in PD, i.e., facial emotion 
expression and emotion recognition, are probably mediated by 
different pathophysiological mechanisms. Indeed, the impaired 
expression of emotions in PD is likely to reflect impaired basal 
ganglia loops and abnormal primary motor and pre-motor area 
activation in the frontal lobe. By contrast, the specific impair-
ment of emotion recognition in PD is likely to reflect a pre-
dominant involvement of limbic system components, including 
the insula and amygdala (5–9). As an alternative explanation, 
components that regulate facial emotion expression other than 
pure neuromuscular activation, as measured by the kinematic 
analysis, may be related to the recognition of facial emotions 
expressed by others (49).
We acknowledge that our study has certain limitations. First, 
PD is a clinically heterogeneous disorder with different subtypes 
that may be associated with different cognitive and emotional 
correlates; it is thus possible that the different disorder subtypes 
have different impacts on specific deficits of emotional process-
ing. Second, since we only enrolled PD patients whose symptom 
severity was moderate, we do not know whether our results apply 
to other stages of the disease; it is possible that facial emotion 
expression and recognition in the earlier or more advanced 
disease stages differ from those that we observed. Future studies 
should thoroughly assess patients in the various stages of the dis-
ease to clarify this issue. Owing to the relatively small sample size, 
we did not specifically investigate the influence of other factors 
such as gender or age nor did we investigate the possible effect of 
dopaminergic medication because we previously observed that 
dopaminergic medication does not significantly affect voluntary 
facial movements. Finally, it should be borne in mind that we 
decided to examine only mimicked facial emotion expressions 
and not posed emotions using the same pictures of the emotion 
recognition task, and moreover, we assessed facial emotions in 
an experimental setting, without considering spontaneous facial 
emotion expressions, whose pathophysiology may differ from 
that of the mimicked expressions.
cOnclUsiOn
This study provides novel information on altered emotional pro-
cessing in PD. To the best of our knowledge, this is the first study 
that has examined facial expression kinematic abnormalities of 
all the primary emotions and facial recognition abnormalities 
in the same sample of patients with PD. The different patterns 
of impairment observed between facial emotion expression and 
emotion recognition in PD, as well as the lack of any correlation 
between the two abnormalities, point to different underlying 
pathophysiological mechanisms. Both emotion expression and 
recognition abnormalities should thoroughly be assessed in PD 
because they may worsen social interaction and the quality of life 
in PD patients.
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